Kahn Brothers Group Portfolio - Dec 31, 2025
Kahn Brothers Group, Thomas Graham, Alan, Irving Kahns, has built a diversified portfolio of 53 publicly traded holdings with a total market value of $564.7M as of Dec 31, 2025. This comprehensive analysis examines the latest 13F filing data to understand the investment strategy and recent portfolio adjustments.
The portfolio demonstrates a concentrated approach to stock selection, with the top holding representing 18.1% of the total portfolio value. The top 5 holdings account for 56.3% of the overall portfolio allocation.
Recent portfolio activity shows 10 significant position adjustments, indicating active portfolio management and strategic repositioning. These changes reflect the investor's response to market conditions and evolving investment thesis.
Portfolio Statistics
Top Holdings Analysis
The portfolio's top holdings reveal the investor's core investment thesis and sector preferences. The largest position in Citigroup Inc (C) represents 18.1% of the total portfolio, valued at $102.3M.
| Rank | Symbol | Company | Value | Portfolio % | Change |
|---|---|---|---|---|---|
| 1 | C | Citigroup Inc | $102.3M | 18.1% | -0.0% |
| 2 | BAYRY | Bayer AG Spons ADR | $73.1M | 12.9% | -0.5% |
| 3 | NYCB | Flagstar Financial, Inc. | $52.6M | 9.3% | -2.8% |
| 4 | MRK | Merck & Co. Inc. | $45.3M | 8.0% | -0.8% |
| 5 | DIS | Walt Disney | $44.9M | 7.9% | -0.0% |
For a complete analysis of all holdings and detailed portfolio breakdown by sector and market cap, visit our comprehensive holdings page.
Recent Portfolio Activity
Recent portfolio adjustments provide insights into the investor's evolving strategy and market outlook.
The following table shows the top 10 most significant position changes from
recent reporting periods (out of 146 total transactions), sorted by the magnitude of
change.
For a complete history of all portfolio transactions and detailed activity analysis,
visit our comprehensive
activity page.
| Symbol | Company | Quantity Change | Date | Action |
|---|---|---|---|---|
| PFE | Pfizer, Inc. | -153,194 | Dec 31, 2025 | SELL |
| PTEN | Patterson-UTI Energy, Inc. | -143,447 | Dec 31, 2025 | SELL |
| NYCB | None | -119,540 | Dec 31, 2025 | SELL |
| RFL | Rafael Holdings, Inc. | -99,428 | Dec 31, 2025 | SELL |
| GSK | GSK plc | -82,141 | Dec 31, 2025 | SELL |
| BMY | Bristol-Myers Squibb Company | -70,138 | Dec 31, 2025 | SELL |
| BP | BP p.l.c. | -47,205 | Dec 31, 2025 | SELL |
| BAYRY | Bayer A.G. | -32,962 | Dec 31, 2025 | SELL |
| OGN | Organon & Co. | +12,606 | Dec 31, 2025 | BUY |
| AR | Antero Resources Corporation | -11,600 | Dec 31, 2025 | SELL |
Investment Strategy Insights
Kahn Brothers Group's investment approach can be analyzed through several key metrics. The portfolio's concentration in top holdings suggests a high-conviction investment strategy, with significant positions in companies that align with the investor's long-term thesis.
The largest position in Citigroup Inc (C) demonstrates strong conviction in this particular investment opportunity. Recent activity shows a decrease of 0.0% in this position, indicating active portfolio management and strategic positioning.
Portfolio turnover can be assessed through recent activity patterns. The 10 most significant transactions shown here (out of 146 total transactions) suggest a highly active approach to portfolio management, with frequent strategic adjustments and position changes.
Additional Analysis
Complete Holdings
View all 53 holdings with detailed analysis
Trading Activity
Track all portfolio transactions and position changes
Performance Metrics
Analyze profit, winning trades, and investment returns
Sector Allocation
Analyze portfolio breakdown by sector and industry
Kahn Brothers Group's portfolio as of Dec 31, 2025 reflects a strategic approach to equity investing with 53 holdings valued at $564.7M. The concentrated position in Citigroup Inc and other top holdings demonstrates the investor's confidence in specific investment themes and long-term value creation opportunities. Recent activity indicates ongoing portfolio optimization and strategic repositioning.
For the most current portfolio data and detailed analysis, refer to the latest SEC 13F filings and our comprehensive holdings and activity pages, which are updated regularly with the latest filing information.
Other Investor Portfolios
- Alex Roepers
- B. Tweedy, Ch. Browne
- Bill Gates
- Bruce Berkowitz
- C.T. Fitzpatrick
- Carl Icahn
- Connor Haley
- Daniel Loeb
- David Jeffrey Fear
- David Katz
- Edgar Wachenheim III
- Greg Alexander
- Guy Spier
- Jeffrey Ubben
- Michael Lindsell, Nick Train
- Nathaniel Simons
- Nelson Peltz
- Pat Dorsey
- Ravenel Boykin Curry IV
- Richard Pzena
- Ruane, Cunniff & Goldfarb
- Terry Smith
- V. D. Dodge, E. M. Cox
- Warren Buffett